| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 848 | 556 | 2357 | 25 |
Clinical Lymphoma, Myeloma & Leukemia was organized to reinforce research efforts on Internal medicine, Oncology, Multiple myeloma, Cancer research and Gastroenterology. Discussions in it are anchored in the subject of Internal medicine and the similar topic of Surgery. The studies on Oncology discussed can also contribute to research in the domains of Immunology, Transplantation and Rituximab.
The journal centers on topics in Immunology, with a focus on Chronic lymphocytic leukemia. Transplantation research discussed connects with the study of Stem cell. The Multiple myeloma works featured in it incorporate elements from Newly diagnosed and Dexamethasone.
The study of Lymphoma, which falls within the realm of Pathology, was the main focus of the presentations. The study on Myeloid leukemia presented is investigated in conjunction with research in Leukemia.
The main points discussed in the published articles deal with Internal medicine, Lymphoma, Surgery, Gastroenterology and Immunology. The journal publications dive deep in exploring the relationship between the study of Internal medicine and Oncology. The works on Lymphoma tackled in the journal papers bring together disciplines like Fluorodeoxyglucose and Positron emission tomography.
The journal mostly deals with topics like Internal medicine, Oncology, Context (language use), Gastroenterology and Lymphoma. As a part of Clinical Lymphoma, Myeloma & Leukemia, discussions in Internal medicine involve topics like Myeloid leukemia, Multiple myeloma, Chemotherapy, Refractory and Adverse effect. The Multiple myeloma study tackled is a key component of adjacent topics in the area of Dexamethasone.
The research on Oncology featured in Clinical Lymphoma, Myeloma & Leukemia combines topics in other fields like Regimen, Venetoclax, Chronic lymphocytic leukemia, Disease and Transplantation. While it focused on Gastroenterology, it was also able to explore topics like Anemia and Neutropenia. Diffuse large B-cell lymphoma, Rituximab and Follicular lymphoma studies are all carried out as a component of the study in Lymphoma presented.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Clinical Lymphoma, Myeloma & Leukemia (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Clinical Lymphoma, Myeloma & Leukemia (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 18.97% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.11% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.59% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 17.56% of all publications and 43.74% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Another aspect of importance to anyone interested in research in this field might be to explore how to transform the knowledge they gain from reading Clinical Lymphoma, Myeloma & Leukemia, into action. One way is by seeking careers that stem from these research topics. There are several career opportunities, including academic roles to clinical positions in Internal Medicine, Oncology, Surgery, Gastroenterology, and Immunology. For instance, a career as a Nurse Specialized in Oncology represents an opportunity to take these findings from paper to practice, treating patients affected by Lymphoma, Myeloma & Leukemia. Further career opportunities include working as a researcher or a healthcare professional in different hospital settings, universities, or medical institutions around the globe. But before diving right into these careers, it is crucial to meet specific licensing and education requirements. Take, for example, a career in nursing: you will need to pass specific exams, meet some internship hours, and fulfill certain educational requirements to receive a relevant license. Should you be interested in exploring this further, particularly if you're in the United States, one place to check would be the washington nursing license requirements, for a detailed guide on the nursing license education requirements in the state of Washington. Similar resources might be available for other states and regions, so it's worth exploring! Remember, your career path in Clinical Lymphoma, Myeloma & Leukemia research can be as versatile and dynamic as the research topics themselves! So, keep reading, keep exploring, and keep following your passion!
Maria Victoria Mateos;Pieter Sonneveld;Vania Hungria;Ajay K. Nooka
(2020)Hervé Avet-Loiseau;Heinz Ludwig;Ola Landgren;Bruno Paiva
(2020)Guillaume Richard-Carpentier;Elias Jabbour;Nicholas J. Short;Caitlin R. Rausch
(2020)Ajai Chari;Dorothy Romanus;Antonio Palumbo;Marlo Blazer
(2020)Bridget K. Marcellino;Srdan Verstovsek;John Mascarenhas
(2020)David Sallman;Adam Asch;Suman Kambhampati;Monzr Al Malki
(2021)For those interested in Medicine in the USA, exploring related online degrees can open up diverse career pathways. Nursing is a popular and accessible option. Many aspiring nurses seek programs without additional entrance hurdles. Programs such as nursing school without teas exams offer a smoother admission process, making the transition into healthcare smoother.
For professionals aiming to enter or advance in healthcare management, affordable and flexible education options are available. Several affordable online mha programs provide essential leadership skills and industry knowledge without the need to pause your career.
If a quicker route into medical assisting or patient care appeals to you, consider exploring fasttrack medical courses. These programs help students enter the workforce rapidly and gain practical experience in healthcare settings.
For those focused on research or academic leadership in nursing, pursuing advanced degrees like a phd in nursing online programs offers a flexible, affordable path to contribute significantly to the medical field while balancing other responsibilities.
